- ROUNDTABLE: Pharmacy’s future in sync with technology
- Sanofi: Nasacort first nasal corticosteroid available without a prescription
- 21 health industry groups address FDA on proposed changes to generic drug label rules
- Roxane Labs' generic prostate drug gets tentative approval from FDA
- FDA advisory panel to consider OTC status of NSAIDs
BALTIMORE — The Food and Drug Administration has approved a generic drug for insomnia made by Lupin, the drug maker said.
The FDA approved zolpidem tartrate extended-release tablets in the 6.25-mg and 12.5-mg strengths, a generic version of Sanofi's Ambien CR.
The branded version of the drug had sales of $366 million during the 12-month period ended in March, according to IMS Health.